
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated January 17, 2024, titled "Bayer and Sun Pharma sign marketing and distribution agreement for second brand of Finerenone in India ".
Filed with NSE ·

Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated January 17, 2024, titled "Bayer and Sun Pharma sign marketing and distribution agreement for second brand of Finerenone in India ".
6ix hasn’t read this filing yet.
Sun Pharmaceutical Industries Limited on 6ix
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries